Public Employees Retirement System of Ohio Acquires 564 Shares of Perrigo Company plc $PRGO

Public Employees Retirement System of Ohio raised its holdings in Perrigo Company plc (NYSE:PRGO) by 1.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 42,290 shares of the company’s stock after purchasing an additional 564 shares during the quarter. Public Employees Retirement System of Ohio’s holdings in Perrigo were worth $1,130,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently bought and sold shares of the business. GAMMA Investing LLC grew its stake in Perrigo by 32.7% in the 2nd quarter. GAMMA Investing LLC now owns 4,891 shares of the company’s stock valued at $131,000 after purchasing an additional 1,206 shares during the period. Clear Harbor Asset Management LLC lifted its position in shares of Perrigo by 7.1% during the 2nd quarter. Clear Harbor Asset Management LLC now owns 12,000 shares of the company’s stock valued at $321,000 after buying an additional 800 shares during the last quarter. Harbor Capital Advisors Inc. lifted its position in shares of Perrigo by 1.0% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 57,625 shares of the company’s stock valued at $1,540,000 after buying an additional 570 shares during the last quarter. MassMutual Private Wealth & Trust FSB lifted its position in shares of Perrigo by 54.6% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,201 shares of the company’s stock valued at $32,000 after buying an additional 424 shares during the last quarter. Finally, Voya Investment Management LLC lifted its position in shares of Perrigo by 4.6% during the 1st quarter. Voya Investment Management LLC now owns 20,446 shares of the company’s stock valued at $573,000 after buying an additional 903 shares during the last quarter. Institutional investors own 95.91% of the company’s stock.

Perrigo Price Performance

Shares of NYSE PRGO opened at $22.52 on Friday. The firm has a market capitalization of $3.10 billion, a P/E ratio of -38.83 and a beta of 0.43. The company has a quick ratio of 1.24, a current ratio of 2.32 and a debt-to-equity ratio of 0.81. The stock’s 50-day simple moving average is $23.26 and its two-hundred day simple moving average is $25.40. Perrigo Company plc has a twelve month low of $20.51 and a twelve month high of $30.93.

Perrigo (NYSE:PRGO) last announced its quarterly earnings data on Wednesday, August 6th. The company reported $0.57 earnings per share for the quarter, missing analysts’ consensus estimates of $0.59 by ($0.02). The firm had revenue of $1.06 billion for the quarter, compared to analysts’ expectations of $1.08 billion. Perrigo had a negative net margin of 1.86% and a positive return on equity of 9.09%. The business’s quarterly revenue was down .9% on a year-over-year basis. During the same period in the prior year, the business posted $0.53 earnings per share. As a group, equities analysts anticipate that Perrigo Company plc will post 2.56 EPS for the current fiscal year.

Perrigo Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 16th. Investors of record on Friday, August 29th were issued a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a dividend yield of 5.2%. The ex-dividend date of this dividend was Friday, August 29th. Perrigo’s dividend payout ratio (DPR) is currently -200.00%.

Insider Transactions at Perrigo

In other news, CFO Eduardo Guarita Bezerra acquired 3,000 shares of the firm’s stock in a transaction that occurred on Monday, August 18th. The shares were bought at an average cost of $22.74 per share, with a total value of $68,220.00. Following the acquisition, the chief financial officer owned 48,949 shares in the company, valued at approximately $1,113,100.26. This represents a 6.53% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Abigail Lennox acquired 1,255 shares of the firm’s stock in a transaction that occurred on Monday, September 8th. The shares were purchased at an average cost of $22.41 per share, for a total transaction of $28,124.55. Following the completion of the acquisition, the executive vice president owned 1,255 shares in the company, valued at $28,124.55. This represents a ∞ increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders purchased 10,118 shares of company stock valued at $232,699. 0.70% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

PRGO has been the topic of a number of recent research reports. Canaccord Genuity Group dropped their price target on Perrigo from $42.00 to $40.00 and set a “buy” rating on the stock in a research report on Thursday, August 7th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Perrigo in a research report on Saturday, September 27th. Wall Street Zen raised Perrigo from a “hold” rating to a “buy” rating in a research report on Sunday, September 28th. Finally, JPMorgan Chase & Co. dropped their price target on Perrigo from $38.00 to $35.00 and set an “overweight” rating on the stock in a research report on Thursday, August 7th. Two analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Perrigo presently has an average rating of “Hold” and a consensus target price of $34.00.

Perrigo Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.